Cooper Financial Group’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$276K Sell
6,464
-6,896
-52% -$308K 0.02% 356
2026
Q1
$644K Buy
13,360
+2,432
+22% +$113K 0.07% 218
2025
Q4
$530K Sell
10,928
-1,906
-15% -$94.5K 0.06% 235
2025
Q3
$606K Sell
12,834
-3,150
-20% -$152K 0.07% 206
2025
Q2
$772K Buy
15,984
+314
+2% +$16K 0.09% 178
2025
Q1
$869K Buy
15,670
+2,338
+18% +$127K 0.11% 163
2024
Q4
$643K Buy
13,332
+274
+2% +$13.9K 0.08% 197
2024
Q3
$753K Buy
13,058
+8,155
+166% +$440K 0.1% 183
2024
Q2
$238K Buy
+4,903
New +$237K 0.04% 339

Other funds holding SNY

Cooper Financial Group's SNY Position: Q2 2026 in Review

Cooper Financial Group reduced its Sanofi (SNY) stake by 52% in Q2 2026, selling an estimated $308K and leaving 6,464 shares worth $276K. The position accounts for 0.02% of the portfolio, ranked #356.

Cooper Financial Group first reported a position in SNY in Q2 2024 and has held it in 9 quarters since. The position peaked at $869K in Q1 2025. 128 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Cooper Financial Group held 6,464 shares of Sanofi worth $276K as of Q2 2026.
  • Cooper Financial Group sold 6,896 Sanofi shares in Q2 2026, an estimated $308K.
  • Sanofi made up 0.02% of Cooper Financial Group's portfolio in Q2 2026, its #356 holding.
  • Cooper Financial Group first reported a position in Sanofi in Q2 2024 and has held it in 9 quarters since.
  • Cooper Financial Group's Sanofi position peaked at $869K in Q1 2025.
  • 128 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Cooper Financial Group's 13F filing for Q2 2026, filed 8 Jul 2026.